ClinVar Miner

Submissions for variant NM_000551.4(VHL):c.639T>C (p.Asp213=)

gnomAD frequency: 0.00004  dbSNP: rs775624944
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000342034 SCV000439638 uncertain significance Von Hippel-Lindau syndrome 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000679045 SCV000515250 likely benign not provided 2020-04-17 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001081661 SCV000563221 likely benign Chuvash polycythemia; Von Hippel-Lindau syndrome 2025-01-28 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000679045 SCV000805360 likely benign not provided 2017-12-11 criteria provided, single submitter clinical testing
Ambry Genetics RCV001025221 SCV001187368 likely benign Hereditary cancer-predisposing syndrome 2018-04-25 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
All of Us Research Program, National Institutes of Health RCV000342034 SCV004841679 likely benign Von Hippel-Lindau syndrome 2023-12-18 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV005238930 SCV005884129 benign not specified 2024-12-11 criteria provided, single submitter clinical testing Variant summary: VHL c.639T>C results in a synonymous change. Consensus agreement among computation tools predict no significant impact on normal splicing (TrAP). However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4e-05 in 249864 control chromosomes. The observed variant frequency is approximately 1.92 fold of the estimated maximal expected allele frequency for a pathogenic variant in VHL causing Von Hippel-Lindau Syndrome phenotype (2.1e-05). To our knowledge, no occurrence of c.639T>C in individuals affected with Von Hippel-Lindau Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 342404). Based on the evidence outlined above, the variant was classified as benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.